Nutrition & Exercise to Improve Protein Metabolism & Prevent Sarcopenia in Aging

营养

基本信息

  • 批准号:
    7533392
  • 负责人:
  • 金额:
    $ 41.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-08-01 至 2013-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our general hypothesis is that nutritional factors and inactivity play significant roles in the development of sarcopenia. Thus, age-specific prolonged interventions including nutritional manipulations and/or exercise may help to reduce, stabilize, or even reverse the loss of muscle mass and strength with age. However, previous studies attempting to improve muscle mass in older subjects using nutritional supplementation had little success, due to a trend for elders to compensate for the energy delivered by nutritional supplements with reduced food intake. Therefore, effective nutritional supplements for the elderly should be more anabolic than the same amount of ordinary food, to limit the caloric content and maximize the anabolic efficiency (anabolic effect/energy delivered). Our preliminary data indicate that essential amino acids are the most efficient nutrients for the acute stimulation of muscle protein anabolism, and that long term utilization may also improve muscle mass in older subjects. Additionally, inactivity is another likely contributor to sarcopenia. Exercise increases not only muscle mass and strength, but also energy expenditure. Hence, exercise may improve the response of muscle to nutritional supplementation in older subjects via increased energy requirements and food consumption, thereby allowing for the achievement of true supplementation. Although resistance exercise is the most anabolic form of physical activity, compliance in the outpatient setting may be disappointing. Aerobic exercise is more appealing and easier to implement in the older population. Our preliminary data indicate that aerobic exercise acutely increases muscle protein synthesis, normalizes muscle perfusion, and reduces the age-related insulin resistance of muscle proteins. Thus, aerobic exercise may improve muscle protein metabolism, strength, function and even mass in older people, particularly when combined with nutritional interventions. We will test the following specific hypotheses in older sedentary subjects: 1. A highly efficient nutritional supplement will increase, with prolonged treatment, muscle mass and strength by stimulating net muscle protein synthesis. 2. Progressive aerobic training will increase muscle strength and function by stimulating muscle protein turnover and improving muscle perfusion and muscle quality. 3. The highly efficient nutritional supplementation combined with progressive aerobic training will increase muscle mass, strength, and function more than either intervention alone by additively stimulating net muscle protein synthesis, and improving muscle perfusion and muscle quality. Our goal is to establish if specific interventions that can acutely increase muscle protein synthesis can also effectively translate into increased muscle mass and performance in older sedentary people. PUBLIC HEALTH RELEVANCE: Our general goal is to find simple and safe interventions to prevent and treat the loss of muscle mass, strength, and function in older persons. Muscle weakness with aging leads to frailty, disability and loss of independence, increasing the risk of institutionalization and death, and greatly increasing healthcare costs. Based on our preliminary data, we propose that prolonged nutritional supplementation with highly effective, age-specific supplements and/or endurance training will enhance muscle mass, strength and function in older persons by increasing muscle growth and quality.
描述(由申请人提供):我们的一般假设是营养因素和不活动在肌肉减少症的发展中起重要作用。因此,包括营养操作和/或锻炼在内的针对年龄的长期干预可能有助于减少、稳定甚至逆转肌肉质量和力量随年龄的损失。然而,以前试图使用营养补充剂改善老年受试者肌肉质量的研究几乎没有成功,因为老年人倾向于通过减少食物摄入来补偿营养补充剂提供的能量。因此,老年人有效的营养补充剂应该比相同数量的普通食物更具合成代谢,以限制热量含量并最大限度地提高合成代谢效率(合成代谢效果/能量传递)。我们的初步数据表明,必需氨基酸是最有效的营养素的急性刺激肌肉蛋白质的抗氧化剂,长期利用也可以提高肌肉质量在老年人。此外,不活动是肌肉减少症的另一个可能因素。运动不仅增加肌肉质量和力量,还增加能量消耗。因此,运动可以通过增加能量需求和食物消耗来改善老年受试者肌肉对营养补充的反应,从而实现真正的补充。虽然抗阻运动是身体活动中最具合成代谢作用的形式,但门诊患者的依从性可能令人失望。有氧运动在老年人中更有吸引力,更容易实施。我们的初步数据表明,有氧运动急性增加肌肉蛋白质的合成,正常化肌肉灌注,并减少与年龄相关的肌肉蛋白的胰岛素抵抗。因此,有氧运动可以改善老年人的肌肉蛋白质代谢,力量,功能甚至质量,特别是当与营养干预相结合时。我们将在老年久坐不动的受试者中测试以下特定假设:1。一个高效的营养补充剂将增加,与长期治疗,肌肉质量和力量,通过刺激净肌肉蛋白质的合成。2.渐进式有氧训练将通过刺激肌肉蛋白质周转和改善肌肉灌注和肌肉质量来增加肌肉力量和功能。3.高效的营养补充与渐进式有氧训练相结合,通过增加净肌肉蛋白质合成,改善肌肉灌注和肌肉质量,比单独的干预措施更能增加肌肉质量,力量和功能。我们的目标是确定可以急剧增加肌肉蛋白质合成的特定干预措施是否也可以有效地转化为老年久坐人群的肌肉质量和性能增加。 公共卫生关系:我们的总体目标是找到简单而安全的干预措施,以预防和治疗老年人肌肉质量,力量和功能的丧失。随着年龄的增长,肌肉无力会导致虚弱、残疾和丧失独立性,增加机构化和死亡的风险,并大大增加医疗保健成本。根据我们的初步数据,我们提出,长期营养补充与高效,年龄特定的补充剂和/或耐力训练将提高肌肉质量,力量和功能,在老年人通过增加肌肉生长和质量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Elena Volpi其他文献

Elena Volpi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Elena Volpi', 18)}}的其他基金

Closeout Bridging Administrative Supplement to R01AG049611
R01AG049611 的清仓桥接管理补充
  • 批准号:
    10281452
  • 财政年份:
    2016
  • 资助金额:
    $ 41.31万
  • 项目类别:
Identifying therapeutic targets of accelerated sarcopenia
确定加速肌少症的治疗靶点
  • 批准号:
    9056065
  • 财政年份:
    2016
  • 资助金额:
    $ 41.31万
  • 项目类别:
NUTRITION & EXERCISE TO IMPROVE PROTEIN METABOLISM & PREVENT SARCOPENIA IN AGING
营养
  • 批准号:
    7952172
  • 财政年份:
    2009
  • 资助金额:
    $ 41.31万
  • 项目类别:
CLINICAL TRIAL: INSULIN AND SARCOPENIA IN THE ELDERLY (CYCLE NO, 2)
临床试验:老年人的胰岛素和肌肉减少症(第 2 周期)
  • 批准号:
    7952154
  • 财政年份:
    2009
  • 资助金额:
    $ 41.31万
  • 项目类别:
CLINICAL TRIAL: NUTRITIONAL INTERVENTIONS FOR MAXIMAL MUSCLE GAIN IN MIDDLE-AGED
临床试验:中年人最大肌肉增长的营养干预
  • 批准号:
    7952163
  • 财政年份:
    2009
  • 资助金额:
    $ 41.31万
  • 项目类别:
Nutrition & Exercise to Improve Protein Metabolism & Prevent Sarcopenia in Aging
营养
  • 批准号:
    8073013
  • 财政年份:
    2008
  • 资助金额:
    $ 41.31万
  • 项目类别:
CLINICAL TRIAL: NUTRITIONAL INTERVENTIONS FOR MAXIMAL MUSCLE GAIN IN MIDDLE-AGED
临床试验:中年人最大肌肉增长的营养干预
  • 批准号:
    7719200
  • 财政年份:
    2008
  • 资助金额:
    $ 41.31万
  • 项目类别:
Nutrition & Exercise to Improve Protein Metabolism & Prevent Sarcopenia in Aging
营养
  • 批准号:
    8141802
  • 财政年份:
    2008
  • 资助金额:
    $ 41.31万
  • 项目类别:
Nutrition & Exercise to Improve Protein Metabolism & Prevent Sarcopenia in Aging
营养
  • 批准号:
    8277275
  • 财政年份:
    2008
  • 资助金额:
    $ 41.31万
  • 项目类别:
CLINICAL TRIAL: INSULIN AND SARCOPENIA IN THE ELDERLY (CYCLE NO, 2)
临床试验:老年人的胰岛素和肌肉减少症(第 2 周期)
  • 批准号:
    7719189
  • 财政年份:
    2008
  • 资助金额:
    $ 41.31万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.31万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 41.31万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.31万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.31万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.31万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.31万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 41.31万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 41.31万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 41.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 41.31万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了